#893 Keeping aggressive cancer cells in check
#894 Scientists from Charité profiled 168 metabolic markers in blood samples and were able to predict the risk of onset of several diseases with just one test
#895 NUVISAN receives US$ 9.6m grant for a multi-target drug discovery program on novel non-hormonal contraceptive medicines
#896 PRAMOMOLECULAR wants to silence cancer
#897 Algorithms developed at the Max Delbrück Center are able to detect new SARS-CoV-2 variants and other pathogens in wastewater
#898 Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
#899 T-knife Therapeutics Announces Dosing of First Patient with TK-8001 in the IMAG1NE Phase 1/2 Clinical Trial
#900 FyoniBio and Strike Pharma sign a Master Service Agreement covering Cell Line Development for a novel bi-specific therapeutic mAb
#901 BIH Digital Health Accelerator Program 2024
#902 First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
#903 CELLphenomics, KYAN Technologies and Alentis Therapeutics join forces
#904 Data4Life supports developing an early warning system for crises with the digital study DAKI Health
#905 Charité research team discovers central functions of innate immune cells
#906 LABORATORY EQUIPMENT MANUFACTURER KNAUER HONORED AS TOP EMPLOYER
#907 Three proteins in the blood help to early detect type 2 diabetes risk
#908 Eckert & Ziegler establishes German-Chinese joint venture with DC Pharma for the production of radioisotopes
#909 TME PHARMA ANNOUNCES THE INITIATION OF THE LISTING OF PREFERENTIAL SUBSCRIPTION RIGHTS FOR FULLY GUARANTEED €2.7 MILLION CAPITAL INCREASE
#910 How genes and small molecules influence our personal disease risk
#911 Study published in Science by Charité Universitätsmedizin sheds light on the origins of the SARS-CoV-2 variant
#912 Drug for liver disease could protect against infection with SARS-CoV-2 and help COVID-19 patients
#913 BIOTRONIK Opens New Asia-Pacific Hub in Singapore
#914 Competition call for the Deep Tech Award
#915 Charité study shows that algorithm is equivalent to standard of care treatment
#916 Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has discovered an unknown mechanism for how “starvation response” in body cells is triggered
#917 Professor Il-Kang Na named new director of the BIH Charité Clinician Scientist Program
#918 ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
#919 Prof. Dr. Joachim Spranger is the new Dean of Charité
#920 Pioneering method for stem cell diagnostics: Leif S. Ludwig receives Paul Ehrlich and Ludwig Darmstaedter Early Career Award
#921 Scientists of Max Planck Institute for Molecular Genetics have reconstructed chromosomes of patients with a high number of aberrations in their genome that potentially cause disease
#922 ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
#923 Eckert & Ziegler Extends Ga-68 Activities in Japan
#924 JOIN OUR NEXT COHORT
#925 Researchers of Max Delbrück Center develop a new method that is able to identify “zipcodes” that assign a destination to mRNAs
#926 8th BioProScale Symposium 2024
#927 Study in Nature discovers causal mechanism behind rare hereditary diseases
#928 1.3 million euros for ten new projects in 3R research
#929 Identification of disease-causing proteins leads to new potential treatments for diseases like diabetes
#930 Max Delbrück Center reveals the harmful effects of immune cells in hypertension
#931 ProBioGen’s Growth Strategy Continues Successfully
#932 Transparency for clinical trials
#933 Using bone marrow stromal cells instead of transplantation
#934 Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
#935 Patient Monitoring Roundtable No°1 | 2024 – Monitoring in zero gravity: findings from space research (in German)
#936 ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
#937 Cellphenomics’ And Kyan Therapeutics Combined Platforms Provide Best-In-Class Solutions To Support The Biopharma Industry
#938 Max Delbrück Center discovers how non-coding parts of the genome drive evolution
#939 Eckert & Ziegler Receives Manufacturing Authorization for GMP-grade Lutetium-177
#940 How cancer genes become independent
#941 GeneQuine Biotherapeutics Changes Name to GQ Bio Therapeutics, Expands Facilities and Appoints Industry Veteran to Board
#942 Clinical trial run by Charité and the Max Delbrück Center has been awarded a grant of several million euros to test a new immunotherapy approach
#943 Researchers from the Max Delbrück Center and the DZHK are exploring how the effects of a mutated gene that causes severe hypertension but also protects the kidneys from being damaged can be used therapeutically
#944 Max Delbrück Center has investigated how the sensory cells of the vagus nerve react to mechanical stimuli in the esophagus in the process of swallowing
#945 Charité assumes presidency of the European University Hospital Alliance (EUHA)
#946 Max Delbrück Center has developed new technology to study virus infections
#947 Max Delbrück Center has developed a new tool to study complex genome interactions
#948 Scientists from BIH and Max Delbrück Center discover that T cells of the immune system are especially sensitive to genetic disturbances within their mitochondrial power plants
#949 World Health Summit 2023: "A Defining Year for Global Health Action" - Registration for WHS 2023 is open
#950 xTEF 2024 Event | All TEFs Open for Business
#951 New muscle therapy gets fast-track boost - The stem cell therapy developed by MyoPax, a spin-off from the Max Delbrück Center and Charité, could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process
#952 CMC 2024 „DISTILLED“ ONLINE CONFERENCE - Update on Women’s Cancer
#953 Max Delbrück Center scientists contribute to study that created the most comprehensive cell atlas of the human heart which include the cells from which the heartbeat originates
#954 GOOD CLINICAL PRACTICE (GCP) – ONLINE BASIC TRAINING
#955 Preparations for new Einstein Center begin
#956 GOOD CLINICAL PRACTICE
#957 GQ Bio Closes Collaboration Deal with Pacira BioSciences for Development of a Commercial-Scale Manufacturing Process for High-Capacity Adenoviral Vectors
#958 Rapid and Specific Detection of most common Fungal Nail and Skin Infections
#959 Rare kidney disease is genetically decoded
#960 3Z and biotx.ai forge partnership to advance ADHD drug development using AI modelling
#961 Pre-call Announcement
#962 G4A: Growth Track
#963 Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update
#964 Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients
#965 Starting up with highly promising immunotherapies
#966 2024 BIH Digital Health Accelerator Demo Day
#967 Eckert & Ziegler Receives Award for Professional Training
#968 From INNATE to ADAPTIVE Immunity - a question of memory
#969 Scientists from the Max Delbrück Center have created a new zebrafish xenograft platform to screen for novel treatments for glioblastoma
#970 Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials
#971 How stem cells and immune cells communicate - Lisec Artz Award for Simon Haas
#972 Personalized cancer medicine: humans make better treatment decisions than AI - Charité study highlights limits of large language models in precision medicine
#973 Recent Charité study of the mRNA coronavirus vaccines shows how the body builds local immune memory in various organs
#974 Caresyntax Announces Strategic Collaboration with AAICO to Expand AI-based Solutions In Healthcare
#975 Charles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening
#976 Scientists of the Max Delbrück Center describe the role one enzyme plays in removing waste DNA or RNA remains in cells
#977 Eckert & Ziegler and ARTBIO Announce Manufacturing and Supply Partnership for Lead-212 Conjugates
#978 Third ERC Grant for Gaetano Gargiulo from the Max Delbrück Center
#979 For faster access to gene and cell therapies in Europe - EU-funded JOIN4ATMP project aims to overcome regulatory obstacles
#980 Computer-engineered DNA to study cell identities
#981 How COVID-19 affects the brain - Neurological symptoms apparently not a result of SARS-CoV-2 infection of the brain
#982 A new channel for touch
#983 BIOTRONIK Introduces World’s First and Only System CE Approved for Left Bundle Branch Area Pacing (LBBAP) | Biotronik
#984 Bayer and Aignostics to collaborate on next generation precision oncology
#985 Charité Virology is a reference laboratory in the WHO Coronavirus Network CoViNet - Global network of reference laboratories aims to detect and monitor coronaviruses
#986 New Data at LINC 2022 Confirm Passeo-18 Lux Drug-Coated Balloon is a Safe and Effective Treatment in Challenging Patient Groups
#987 Immutep Enters into Second Clinical Trial Collaboration Agreement with Merck KGaA, Darmstadt, Germany, and Pfizer
#988 MIT Covid19 Challenge
#989 GOOD CLINICAL PRACTICE (GCP)
#990 Announcement - 1st German-Swedish Call for Proposals for joint R&D projects by Small and Mediumsized Enterprises (SMEs)
Show more items